The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Siemens Healthineers has reaffirmed its expectation that the negative impact of tariffs will double in its next fiscal year ...

The collaboration will pair biometric data from the Oura ring with data from glucose sensors and insulin pumps.

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

CEO Ivan Tornos said multiple factors emerged late in the quarter that caused the shortfall. Zimmer’s shares plunged more ...

Medtronic reached a critical juncture last month in its quest to build the market for renal denervation, a new device-based ...

National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...

In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce ...

More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent ...

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials.

Discover three strategies for MedTech companies to design streamlined, effective trials and how quality data powers smarter ...